A citation-based method for searching scientific literature

Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
Times Cited: 258



Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu, Nikolaus Schultz, Michael F Berger, Chris Sander, Barry S Taylor, Ronald Ghossein, Ian Ganly, James A Fagin. J Clin Invest 2016
Times Cited: 464




List of shared articles



Times cited

Spatial Distribution Patterns of Clinically Relevant TERT Promoter Mutations in Follicular Thyroid Tumors of Uncertain Malignant Potential: Advantages of the Digital Droplet PCR Technique.
Martin Hysek, Kenbugul Jatta, L Samuel Hellgren, Adam Stenman, Catharina Larsson, Jan Zedenius, C Christofer Juhlin. J Mol Diagn 2021
4

A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing.
Sounak Gupta, Chad M Vanderbilt, Yun-Te Lin, Jamal K Benhamida, Achim A Jungbluth, Satshil Rana, Amir Momeni-Boroujeni, Jason C Chang, Tiffany Mcfarlane, Paulo Salazar,[...]. J Mol Diagn 2021
3

SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies.
Mahesh Saqcena, Luis Javier Leandro-Garcia, Jesper L V Maag, Vatche Tchekmedyian, Gnana P Krishnamoorthy, Prasanna P Tamarapu, Vera Tiedje, Vincent Reuter, Jeffrey A Knauf, Elisa de Stanchina,[...]. Cancer Discov 2021
3

[Diagnostic principles of thyroid tumors in pathology : Relevant changes due to the current WHO classification].
Sarah Theurer, Josefine Rawitzer, Saskia Ting, Kurt Werner Schmid. Pathologe 2021
1

Arms-qPCR Improves Detection Sensitivity of Earlier Diagnosis of Papillary Thyroid Cancers With Worse Prognosis Determined by Coexisting BRAF V600E and Tert Promoter Mutations.
Peng-Cheng Yu, Li-Cheng Tan, Xiao-Li Zhu, Xiao Shi, Roman Chernikov, Arseny Semenov, Ling Zhang, Ben Ma, Yu Wang, Xiao-Yan Zhou,[...]. Endocr Pract 2021
2

Molecular-Driven Therapy in Advanced Thyroid Cancer.
Kevin C Miller, Ashish V Chintakuntlawar. Curr Treat Options Oncol 2021
0

Immune Landscape of Thyroid Cancers: New Insights.
Elisa Menicali, Martina Guzzetti, Silvia Morelli, Sonia Moretti, Efisio Puxeddu. Front Endocrinol (Lausanne) 2021
0

Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
L Samuel Hellgren, Ann Olsson, Ann Kaufeldt, Johan O Paulsson, Martin Hysek, Adam Stenman, Jan Zedenius, Catharina Larsson, Anders Höög, C Christofer Juhlin. J Clin Pathol 2021
0

Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.
Assaf Moore, Yael Bar, Corinne Maurice-Dror, Inbar Finkel, Hadar Goldvaser, Elizabeth Dudnik, Daniel A Goldstein, Noa Gordon, Salem Billan, Orit Gutfeld,[...]. Medicine (Baltimore) 2021
0

Preoperative detection of the TERT promoter mutations in papillary thyroid carcinomas.
Tomoe Nakao, Michiko Matsuse, Vladimir Saenko, Tatiana Rogounovitch, Aya Tanaka, Keiji Suzuki, Miyoko Higuchi, Hisanori Sasai, Tsutomu Sano, Mitsuyoshi Hirokawa,[...]. Clin Endocrinol (Oxf) 2021
0



Molecular therapeutics for anaplastic thyroid cancer.
Nikita Pozdeyev, Madison M Rose, Daniel W Bowles, Rebecca E Schweppe. Semin Cancer Biol 2020
10

Utilities of RAS Mutations in Preoperative Fine Needle Biopsies for Decision Making for Thyroid Nodule Management: Results from a Single-Center Prospective Cohort.
Haixia Guan, Gianluca Toraldo, Sandra Cerda, Frederick A Godley, Sowmya R Rao, David McAneny, Gerard Doherty, Lewis Braverman, Stephanie L Lee. Thyroid 2020
15

Intratumoral Genetic Heterogeneity in Papillary Thyroid Cancer: Occurrence and Clinical Significance.
Laura Fugazzola, Marina Muzza, Gabriele Pogliaghi, Mario Vitale. Cancers (Basel) 2020
15

Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas.
Vincent Cracolici, Lauren L Ritterhouse, Jeremy P Segal, Rutika Puranik, Pankhuri Wanjari, Sabah Kadri, Megan Parilla, Nicole A Cipriani. Am J Surg Pathol 2020
4

Genetic Alterations in Pediatric Thyroid Cancer Using a Comprehensive Childhood Cancer Gene Panel.
Ali S Alzahrani, Meshael Alswailem, Anwar Ali Alswailem, Hindi Al-Hindi, Ewa Goljan, Nourah Alsudairy, Mohamed Abouelhoda. J Clin Endocrinol Metab 2020
8


Late-onset distant metastases confer poor prognosis in patients with well-differentiated thyroid cancer.
Chan Kwon Jung, Sohee Lee, Ja Seong Bae, Dong-Jun Lim. Gland Surg 2020
0

The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis.
Ling Zhao, Lin Wang, Xiaomeng Jia, Xiaodong Hu, Ping Pang, Sitong Zhao, Yajing Wang, Jing Wang, Yingshi Zhang, Zhaohui Lyu. Front Oncol 2020
3

T-Box Transcription Factor 22 Is an Immune Microenvironment-Related Biomarker Associated With the BRAF V600E Mutation in Papillary Thyroid Carcinoma.
Xubin Dong, Jingjing Song, Jing Hu, Cheng Zheng, Xiaohua Zhang, Haiguang Liu. Front Cell Dev Biol 2020
1

Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
Ali S Alzahrani, Avaniyapuram Kannan Murugan, Ebtesam Qasem, Meshael M Alswailem, Balgees AlGhamdi, Yosra Moria, Hindi Al-Hindi. Endocrine 2019
7

Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer.
Shikha Saini, Ajay V Maker, Kenneth D Burman, Bellur S Prabhakar. Biochim Biophys Acta Rev Cancer 2019
3

Genetic-guided Risk Assessment and Management of Thyroid Cancer.
Mingzhao Xing. Endocrinol Metab Clin North Am 2019
18

Coding Molecular Determinants of Thyroid Cancer Development and Progression.
Veronica Valvo, Carmelo Nucera. Endocrinol Metab Clin North Am 2019
7

Short Review: Genomic Alterations in Hürthle Cell Carcinoma.
Ian Ganly, David G McFadden. Thyroid 2019
17

Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma.
Junko Akaishi, Tetsuo Kondo, Kiminori Sugino, Yuna Ogimi, Chie Masaki, Kiyomi Y Hames, Tomonori Yabuta, Chisato Tomoda, Akifumi Suzuki, Kenichi Matsuzu,[...]. World J Surg 2019
6

Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases.
Dilmi Perera, Ronald Ghossein, Niedzica Camacho, Yasin Senbabaoglu, Venkatraman Seshan, Juan Li, Nancy Bouvier, Laura Boucai, Agnes Viale, Nicholas D Socci,[...]. J Clin Endocrinol Metab 2019
8

TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.
Aya Tanaka, Michiko Matsuse, Vladimir Saenko, Tomoe Nakao, Kosho Yamanouchi, Chika Sakimura, Hiroshi Yano, Eijun Nishihara, Mitsuyoshi Hirokawa, Keiji Suzuki,[...]. Thyroid 2019
17

Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
Maria E Cabanillas, Mabel Ryder, Camilo Jimenez. Endocr Rev 2019
56

Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor.
Sevim Dalva-Aydemir, Cemaliye Boylu Akyerli, Şirin Kılıçturgay Yüksel, Hilal Keskin, Mustafa Cengiz Yakıcıer. OMICS 2019
3

Molecular Alterations in Thyroid Carcinoma.
Mohamed Rizwan Haroon Al Rasheed, Bin Xu. Surg Pathol Clin 2019
10

Genomic Hallmarks of Thyroid Neoplasia.
Thomas J Giordano. Annu Rev Pathol 2018
25

Long noncoding RNAs: emerging players in thyroid cancer pathogenesis.
Avaniyapuram Kannan Murugan, Arasambattu Kannan Munirajan, Ali S Alzahrani. Endocr Relat Cancer 2018
82

Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
Giorgia Acquaviva, Michela Visani, Andrea Repaci, Kerry J Rhoden, Dario de Biase, Annalisa Pession, Tallini Giovanni. Histopathology 2018
52